Letter: Neutropenia associated with metiamide.
D000380:Agranulocytosis / Q000139:chemically induced*; D001853:Bone Marrow / Q000473:pathology; D001854:Bone Marrow Cells; D002452:Cell Count; D002986:Clinical Trials as Topic; D004381:Duodenal Ulcer / Q000097:blood / Q000188:drug therapy; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced*; D013440:Sulfides / Q000009:adverse effects / Q000627:therapeutic use; D013890:Thiourea / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013997:Time Factors
D006634:Histamine H1 Antagonists; D007093:Imidazoles; D013440:Sulfides; D013890:Thiourea